Colin Cooper

14.4k total citations
28 papers, 1.1k citations indexed

About

Colin Cooper is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Colin Cooper has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Colin Cooper's work include Prostate Cancer Treatment and Research (11 papers), Molecular Biology Techniques and Applications (6 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Colin Cooper is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Molecular Biology Techniques and Applications (6 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Colin Cooper collaborates with scholars based in United Kingdom, Jordan and United States. Colin Cooper's co-authors include Dmitri Pchejetski, Heba Alshaker, Rosalind A. Eeles, Mathias Winkler, Robert Huddart, Christopher B. White, Jeremy Clark, Janet Shipley, Sameer Jhavar and Alison Condie and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Colin Cooper

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Cooper United Kingdom 17 639 332 299 208 133 28 1.1k
Vinay Sagar United States 19 712 1.1× 214 0.6× 231 0.8× 361 1.7× 153 1.2× 46 1.3k
Linda M. Murphy United States 12 686 1.1× 252 0.8× 201 0.7× 334 1.6× 126 0.9× 14 1.1k
Janni Mirosevich United States 12 866 1.4× 626 1.9× 236 0.8× 342 1.6× 85 0.6× 18 1.4k
Chuifeng Fan China 20 694 1.1× 331 1.0× 238 0.8× 366 1.8× 110 0.8× 77 1.2k
Qingfu Zhang China 22 816 1.3× 376 1.1× 531 1.8× 377 1.8× 78 0.6× 63 1.4k
H E Zhau United States 12 568 0.9× 305 0.9× 335 1.1× 348 1.7× 65 0.5× 16 1.0k
Angela Celetti Italy 27 1.0k 1.6× 260 0.8× 221 0.7× 561 2.7× 93 0.7× 44 1.5k
Yozo Kawano Japan 19 657 1.0× 331 1.0× 362 1.2× 435 2.1× 97 0.7× 28 1.2k
Zhong‐Sheng Zhao China 25 896 1.4× 305 0.9× 524 1.8× 513 2.5× 189 1.4× 69 1.5k
Jun Hou China 17 673 1.1× 245 0.7× 235 0.8× 288 1.4× 203 1.5× 62 1.1k

Countries citing papers authored by Colin Cooper

Since Specialization
Citations

This map shows the geographic impact of Colin Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Cooper more than expected).

Fields of papers citing papers by Colin Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Cooper. The network helps show where Colin Cooper may publish in the future.

Co-authorship network of co-authors of Colin Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Cooper. A scholar is included among the top collaborators of Colin Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Cooper. Colin Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brewer, Daniel, et al.. (2022). APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types. BMC Biology. 20(1). 117–117. 22 indexed citations
2.
Connell, Shea P., Robert Mills, Hardev Pandha, et al.. (2021). Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy. Cancers. 13(9). 2102–2102. 8 indexed citations
3.
Alshaker, Heba, Qi Wang, Shyam Srivats, et al.. (2017). New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth. Breast Cancer Research and Treatment. 165(3). 531–543. 23 indexed citations
4.
Wang, Qi, Heba Alshaker, Torsten Böhler, et al.. (2017). Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer. Scientific Reports. 7(1). 5901–5901. 62 indexed citations
5.
Ball, Richard Y., Gunes Gundem, Krishna Sethia, et al.. (2015). Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. Journal of Clinical Pathology. 68(3). 212–217. 18 indexed citations
6.
Alshaker, Heba, Qi Wang, Adam E. Frampton, et al.. (2014). Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. Breast Cancer Research and Treatment. 149(1). 59–67. 28 indexed citations
7.
Rigau, Marina, Mireia Oliván, Marta García, et al.. (2013). The Present and Future of Prostate Cancer Urine Biomarkers. International Journal of Molecular Sciences. 14(6). 12620–12649. 56 indexed citations
8.
Ren, Guoping, Xiaoyan Liu, Xueying Mao, et al.. (2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancer. Genes Chromosomes and Cancer. 51(11). 1014–1023. 37 indexed citations
9.
Olmos, David, J. W. Clark, Daniel Brewer, et al.. (2011). An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome.. Journal of Clinical Oncology. 29(15_suppl). 4577–4577. 1 indexed citations
10.
Kudahetti, Sakunthala C., Gabrielle Fisher, Laurence Ambroisine, et al.. (2010). Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology. 42(6). 519–523. 14 indexed citations
11.
Mitra, Anita, Charles Jameson, Yolanda Barbáchano, et al.. (2009). Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology. 55(6). 696–704. 81 indexed citations
12.
13.
Jhavar, Sameer, Alison Reid, Jeremy Clark, et al.. (2007). Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays. Journal of Molecular Diagnostics. 10(1). 50–57. 43 indexed citations
14.
McIntyre, Alan, Brenda Summersgill, Osman Jafer, et al.. (2004). Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones. Oncogene. 23(56). 9142–9147. 33 indexed citations
15.
16.
Smedley, Damian, Rifat Hamoudi, Yong‐Jie Lu, Colin Cooper, & Janet Shipley. (1999). Cloning and Mapping of Members of the MYM Family. Genomics. 60(2). 244–247. 25 indexed citations
17.
Shipley, Janet, Jeremy Clark, Sandra Birdsall, et al.. (1994). The t(X;18) found in synovial sarcoma involves two distinct loci on the X chromosome. Cancer Genetics and Cytogenetics. 77(2). 199–199. 1 indexed citations
18.
Condie, Alison, Rosalind A. Eeles, Anne‐Lise Børresen, et al.. (1993). Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Human Mutation. 2(1). 58–66. 88 indexed citations
19.
Scambler, Peter, Brandon J. Wainwright, Michèle Ramsay, et al.. (1990). Analysis of the transgenome of MET transfectant cell lines reveals that MET activation is accompanied by an interstitial insertion. Human Genetics. 84(3). 274–8. 1 indexed citations
20.
Williamson, R., Brandon J. Wainwright, Colin Cooper, et al.. (1987). The Cystic Fibrosis Locus. Enzyme. 38(1-4). 8–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinay Sagar Breakdown of academic impact, for papers by Linda M. Murphy Breakdown of academic impact, for papers by Janni Mirosevich Breakdown of academic impact, for papers by Chuifeng Fan Breakdown of academic impact, for papers by Qingfu Zhang Breakdown of academic impact, for papers by H E Zhau Breakdown of academic impact, for papers by Angela Celetti Breakdown of academic impact, for papers by Yozo Kawano Breakdown of academic impact, for papers by Zhong‐Sheng Zhao Breakdown of academic impact, for papers by Jun Hou
Rankless by CCL
2026